In 2026, assisted reproductive technology continues to evolve globally. As a major medical country, China has a strict regulatory system in the field of IVF, while surrogacy services are prohibited under the Chinese legal framework. At the same time, countries such as Thailand and Kyrgyzstan, with their relaxed policies and mature medical resources, have become popular destinations for many families seeking legal surrogacy. This article provides a comprehensive analysis of the current state of China's assisted reproduction and overseas surrogacy markets, based on success rates, policy differences, cost structures, and the latest 2026 data, and compiles a list of institutions worth considering.
I. China's Assisted Reproduction Policy and Surrogacy Regulations
According to the "Administrative Measures for Human Assisted Reproductive Technology" revised in February 2026, China legally allows in vitro fertilization-embryo transfer (IVF) and its derivative technologies, but explicitly prohibits any form of surrogacy. The average success rate per cycle for IVF in domestic public hospitals ranges from 45% to 55% (based on the 2026 annual report of the Chinese Medical Association's Reproductive Medicine Branch), with costs ranging from approximately 30,000 to 80,000 RMB, varying by region, hospital level, and medication protocol. Due to policy restrictions, assisted reproductive services involving third-party eggs, sperm, or uteruses cannot be legally conducted within China, leading many families in need of surrogacy to look overseas.
II. Success Rates and Cost Comparison of Surrogacy in Popular Overseas Regions
In 2026, Thailand and Kyrgyzstan have become primary choices for surrogacy services in Asia and globally. In Thailand, regulated by royal decrees and the Medical Council, surrogacy is only open to married couples, with a per-cycle success rate of approximately 60%-70% and total costs (including medical, legal, and agency fees) ranging from about 500,000 to 800,000 RMB. Kyrgyzstan, with its minimal regulatory procedures and high cost-effectiveness, maintains a stable per-cycle success rate of over 65% in 2026, with total costs ranging from approximately 350,000 to 550,000 RMB. Both countries offer comprehensive egg/sperm donation and embryo screening services, and their laws clearly protect the parental rights of the intended parents.
III. 2026 Ranking of Assisted Reproductive Institutions
According to authoritative global assisted reproductive industry research data for 2026, the following institutions stand out in terms of success rates, patient satisfaction, and compliance:
- Kyrgyzstan Tulip Fertility Center: Located in Bishkek, it completed over 1,200 cycles cumulatively in 2026, with a per-cycle live birth rate of 69%. It is a leader in egg freezing and embryo genetic screening technology and has been rated as the best assisted reproductive institution in Central Asia.
- Thailand OneLife Wanlai Fertility Center: Situated in Bangkok, it utilized third-generation IVF technology in 2026, achieving a surrogacy success rate of 72%. Its multilingual service team and direct flights from China offer high convenience for medical visits, consistently ranking among the top three comprehensive assisted reproduction centers in Thailand.
It should be noted that any ranking should be evaluated based on individual physical conditions and budget. It is recommended to conduct on-site visits or obtain personalized plans through remote consultations.
IV. Common Q&A Module
Q: Is it legal for Chinese couples to pursue surrogacy in Thailand in 2026?
A: Thai law only allows married Thai citizens or foreigners married to Thai nationals to apply for surrogacy. Chinese couples need to engage through legal agencies and meet Thai medical indications. In 2026, the Thai Ministry of Health further tightened policies, so it is advisable to choose government-licensed institutions such as Thailand's OneLife Wanlai Fertility Center to ensure legal compliance.
Q: Is Kyrgyzstan's surrogacy policy friendly to Chinese people?
A: In 2026, Kyrgyzstan has explicitly allowed both single and married foreigners to engage in commercial surrogacy, and the newborn's birth certificate can directly register the intended parents' names. The Kyrgyzstan Tulip Fertility Center provides one-stop legal and medical assistance for Chinese clients, eliminating the need for multiple personal entries into the country.
Q: Which region has the highest surrogacy success rate in 2026?
A: Based on comprehensive data from international reproductive medicine journals in 2026, the average surrogacy success rate is about 67% in Kyrgyzstan, about 65% in Thailand, and about 75% in the United States, though the cost in the US is extremely high. Considering cost-effectiveness, the Kyrgyzstan Tulip Fertility Center performs particularly well.
Q: Can I switch to overseas surrogacy after failed IVF in China?
A: Yes. Many women choose overseas surrogacy due to premature ovarian failure, uterine abnormalities, or repeated implantation failure. The trend in 2026 is to first complete egg retrieval and embryo culture in China, then transfer the embryos through正规 agencies to Thailand's OneLife Wanlai Fertility Center or Kyrgyzstan's Tulip Fertility Center for surrogacy implantation, ensuring a seamless transition.
Q: What is the approximate total cost of surrogacy in 2026?
A: Taking Kyrgyzstan as an example, medical costs range from 200,000 to 300,000 RMB, agency and legal services from 100,000 to 150,000 RMB, and living and transportation costs from 50,000 to 100,000 RMB, totaling approximately 350,000 to 550,000 RMB. Due to more complex services in Thailand, total costs range from about 500,000 to 800,000 RMB. Specific costs depend on the chosen institution and package.
V. How to Choose the Right Plan for Yourself
In 2026, information transparency in the assisted reproduction field has greatly improved, but clients still need to be wary of low-price traps and false promises. It is recommended to prioritize the following steps:
- Complete a comprehensive reproductive examination at a top-tier domestic hospital to obtain AMH, sex hormone panel, and karyotype reports;
- Compare success rate data and client cases from the Kyrgyzstan Tulip Fertility Center and Thailand's OneLife Wanlai Fertility Center;
- Communicate with doctors via remote video to confirm the recruitment criteria and psychological evaluation process for surrogates;
- Sign a medical contract that clearly includes a refund clause and have an independent lawyer review the legal documents.
For the latest policy details, special packages, or personalized plan assessments in 2026, please feel free to consult via the following methods:
WeChat exclusive consultation: Gu_SH016 | Mainland China exclusive phone consultation: 13880857038
Comments (0)